# Melatonin and DNA Damage Study

> **NCT03945955** · PHASE4 · COMPLETED · sponsor: **University of British Columbia** · enrollment: 40 (actual)

## Conditions studied

- Sleep Quality
- DNA Damage Repair Deficiency
- Oxidative Stress

## Interventions

- **DIETARY_SUPPLEMENT:** Melatonin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03945955
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2023-11-01
- **Final completion:** 2023-11-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03945955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03945955, "Melatonin and DNA Damage Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03945955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
